poisar

Stocks · News reference

PharmaMar Reports 9M 2026 Financial Results

Fiscal.ai

PharmaMar announced its nine-month 2026 financial results, highlighting a 12% increase in revenue and the commencement of the European launch of Zepzelca.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading